10.2 Fluorescence In Situ Hybridization (FISH) & CISH
Key Takeaways
- Fluorescence In Situ Hybridization (FISH) hybridizes fluorescently labeled single-stranded DNA probes to complementary target sequences directly within intact cell nuclei or metaphase chromosome spreads, preserving spatial and morphological architecture.
- Metaphase FISH requires mitogen-stimulated cell culture (phytohemagglutinin) and spindle arrest (colcemid) to visualize structural rearrangements and gene locations, whereas interphase FISH operates on non-dividing cells and FFPE tissue sections without culturing.
- Dual-color dual-fusion probes detect reciprocal translocations by yielding two yellow fusion signals alongside single native red and green signals (e.g., t(9;22) BCR-ABL1), whereas dual-color break-apart probes identify rearrangement of genes with multiple partners (e.g., ALK, EWSR1, ROS1) when fused signals separate into individual red and green signals.
- Locus-Specific Identifier (LSI) probes measure gene copy number and amplification (e.g., HER2/CEP17 ratio >= 2.0 or average HER2 >= 6.0 signals eligibility for targeted therapy), while Centromeric Enumeration Probes (CEP) quantify chromosome aneuploidy.
- Chromogenic and Silver In Situ Hybridization (CISH/SISH) utilize antibody-enzyme conjugates (peroxidase or alkaline phosphatase) and permanent chromogens (DAB, Fast Red, silver) to permit brightfield microscopy evaluation, morphological integration, and permanent archival storage.
Last updated: August 2026
10.2 Fluorescence In Situ Hybridization (FISH) & CISH
Quick Summary: In situ hybridization (ISH) enables the microscopic visualization and spatial localization of specific nucleic acid sequences within intact morphologically preserved cells, tissue sections, or chromosome spreads. Fluorescence In Situ Hybridization (FISH) utilizes fluorescently tagged DNA or RNA probes to detect chromosomal translocations, microdeletions, gene amplifications, and aneuploidies. While metaphase FISH requires living, proliferating cell cultures arrested in mitosis, interphase FISH operates directly on non-dividing nuclei, peripheral blood smears, bone marrow aspirates, and formalin-fixed paraffin-embedded (FFPE) pathology specimens. Diagnostic probe architectures—including dual-color dual-fusion probes, dual-color break-apart probes, locus-specific identifier (LSI) probes, and centromeric enumeration probes (CEP)—underpin precision oncology and constitutional genetics. Chromogenic In Situ Hybridization (CISH) replaces fluorophores with permanent enzymatic chromogens, allowing evaluation under standard brightfield light microscopy.
1. Principles & Physical Mechanics of In Situ Hybridization
In situ hybridization bridges molecular genetics and cellular pathology. Rather than extracting nucleic acids into solution, ISH preserves the intracellular architecture of the specimen, allowing direct correlation between genetic alterations and histopathological morphology.
IN SITU HYBRIDIZATION MECHANISM
[ Intact Target Cell Nucleus ] [ Formamide + Heat Codenaturation (75°C) ]
+------------------------------+ +------------------------------------------+
| Double-Stranded Target DNA | =======> | Single-Stranded Target + Probe DNA |
| Wrapped in Histone Core | | (Histones Permeabilized by Pepsin) |
+------------------------------+ +------------------------------------------+
|
v [Hybridization at 37°C (16 hrs)]
+------------------------------------------+
| Fluorescent Probe Hybridizes to Target |
| Cot-1 DNA Blocks Repetitive Sequences |
+------------------------------------------+
|
v [Stringency Wash (0.4X SSC at 72°C)]
+------------------------------------------+
| DAPI Counterstain Added |
| View under Epifluorescence Microscope |
+------------------------------------------+
Direct vs. Indirect Probe Labeling
- Direct Labeling: Fluorophores (e.g., Fluorescein/FITC, Rhodamine/Texas Red, Cyanine dyes Cy3/Cy5, SpectrumOrange, SpectrumGreen) are covalently attached directly to deoxynucleotide triphosphates (e.g., SpectrumOrange-dUTP) incorporated into the probe via nick translation or random priming. Direct labeling produces low background, requires no secondary antibody incubation steps, and is the standard in modern commercial FISH kits.
- Indirect Labeling: Probes incorporate reporter haptens (such as Biotin-16-dUTP or Digoxigenin-11-dUTP). Following hybridization and washing, binding is detected using fluorophore-conjugated affinity reagents (e.g., FITC-labeled avidin or rhodamine-labeled anti-digoxigenin antibodies). Indirect labeling provides signal amplification through multi-layer antibody sandwiches but increases background noise.
2. Metaphase FISH vs. Interphase FISH
Clinical cytogenetics laboratories select between metaphase and interphase FISH based on sample viability, clinical urgency, and the specific structural alteration under investigation.
+---------------------------------------------------------------------------------------------------------+
| METAPHASE FISH VS. INTERPHASE FISH |
+---------------------+-----------------------------------+-----------------------------------------------+
| Feature | Metaphase FISH | Interphase FISH |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Cell State** | Viable, actively dividing cells | Non-dividing, quiescent, or fixed cells |
| | arrested in metaphase | ($G_0 / G_1 / S / G_2$ phase nuclei) |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Sample Types** | Fresh heparinized bone marrow, | Bone marrow smears, uncultured peripheral |
| | PHA-stimulated peripheral blood, | blood, touch preps, amniocytes, FFPE tissue |
| | chorionic villi, skin fibroblasts | core biopsies, thin-layer cytology smears |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Mitogen / Arrest**| Requires **Phytohemagglutinin** | **None required**; no cell culture or |
| | (PHA) and **Colcemid** (spindle) | mitotic stimulation needed |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Turnaround Time** | 3 to 14 days (culture dependent) | Rapid: 4 to 24 hours (STAT capabilities) |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Cell Throughput** | Low (typically 10–20 metaphase | High (**200 to 500 interphase nuclei** |
| | spreads analyzed) | systematically scored per specimen) |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Spatial Context** | Identifies specific chromosome, | Cannot determine specific chromosome arm; |
| | arm, band, and complex transloc. | counts total signals per nucleus |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Clinical Focus** | Chromosome mapping, SKY/M-FISH, | Oncology gene amplification (HER2), deletions |
| | complex karyotypic rearrangements | (del(17p)), rapid prenatal aneuploidy (13,18,21)|
+---------------------+-----------------------------------+-----------------------------------------------+
3. FISH Probe Architectures & Diagnostic Configurations
Clinical FISH assays employ four distinct probe designs, each engineered to address specific cytogenetic abnormalities.
DIAGNOSTIC FISH PROBE ARCHITECTURES
1. Centromeric Enumeration (CEP) 2. Locus-Specific Identifier (LSI)
[ Alpha-Satellite Core ] [ Gene of Interest (100–500 kb) ]
(==== CEP17 ====) (======== HER2 / 17q12 ========)
Detects Aneuploidy / Ploidy Detects Amplifications / Deletions
3. Dual-Color Dual-Fusion (Translocation) 4. Dual-Color Break-Apart (Rearrangement)
Gene A (chr 9 / ABL1): [ RED ] 5' Locus: [ RED ] --- [ Breakpoint ] --- 3' Locus: [ GREEN ]
Gene B (chr 22 / BCR): [ GREEN ] Normal: 2 Fused Yellow Signals (Intact)
Normal: 2 Red + 2 Green Rearranged: 1 Fused Yellow + 1 Separate Red + 1 Separate Green
t(9;22): 2 Yellow (Fusions) + 1R + 1G (Detects ANY partner translocation in ALK, EWSR1, ROS1)
+---------------------------------------------------------------------------------------------------------+
| MAJOR CLINICAL FISH PROBE CONFIGURATIONS |
+---------------------+-----------------------------------+-----------------------------------------------+
| Probe Category | Target Sequence & Probe Design | Clinical Applications & Diagnostic Patterns |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Centromeric** | Highly repetitive alpha-satellite | **Chromosomal Aneuploidy Enumeration:** |
| **Enumeration** | DNA sequences located at the | Prenatal rapid screening for Trisomy 13, 18, |
| **Probes (CEP)** | centromere of specific chromosomes| 21, X, and Y; monitoring sex-mismatched bone |
| | (e.g., D17Z1 for chromosome 17) | marrow transplant chimerism; detecting trisomy|
| | | 8 or 12 in myelodysplasia and CLL. |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Locus-Specific** | Unique single-copy genomic DNA | **Gene Amplification & Microdeletion Panels:**|
| **Identifier** | cloned into BAC/PAC vectors | *HER2/neu* (17q12), *MYC* (8q24), *MDM2*, |
| **Probes (LSI)** | (typically 100 to 500 kb long) | *EGFR*; microdeletion syndromes: 22q11.2 |
| | | (DiGeorge), 17p13.1 (*TP53*), 7q31, 5q31. |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Dual-Color** | Two large probes spanning defined | **Reciprocal Balanced Translocations:** |
| **Dual-Fusion** | breakpoints on two chromosomes; | *BCR-ABL1* $t(9;22)$ in CML / ALL; |
| **Probes** | Probe A = Red, Probe B = Green | *PML-RARA* $t(15;17)$ in APL; |
| | | *IGH-CCND1* $t(11;14)$ in Mantle Cell Lymphoma|
| | | **Normal:** 2R, 2G; **Positive:** 2F, 1R, 1G |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Dual-Color** | Two flanking probes spanning the | **Promiscuous Translocation Partners:** |
| **Break-Apart** | 5' (Red) and 3' (Green) regions | *ALK* (2p23) and *ROS1* (6q22) in lung cancer;|
| **(Split) Probes** | of a single gene breakpoint locus | *EWSR1* (22q12) in Ewing Sarcoma; |
| | | *MYC* (8q24), *BCL2* (18q21), *MALT1* (18q21).|
| | | **Normal:** 2F (Yellow); **Rearranged:** 1F,1R,1G|
+---------------------+-----------------------------------+-----------------------------------------------+
| **Whole Chromosome**| Complex cocktail library of | **Cytogenetic Painting (Metaphase ONLY):** |
| **Painting (WCP)** | thousands of overlapping probes | Spectral Karyotyping (SKY) and M-FISH; |
| | covering an entire chromosome | resolving complex marker chromosomes and ring |
| | | chromosomes; identifying cryptic insertions. |
+---------------------+-----------------------------------+-----------------------------------------------+
Signal Interpretation: Dual-Fusion vs. Break-Apart Mechanics
1. Dual-Color Dual-Fusion Translocation Probes (e.g., $t(9;22)(q34.1;q11.2)$ BCR-ABL1)
- Normal Diploid Nucleus: Contains two intact copies of chromosome 9 (ABL1, labeled in Red) and two intact copies of chromosome 22 (BCR, labeled in Green). Signal pattern = 2 Red + 2 Green (2R, 2G).
- Reciprocal Translocation Positive Nucleus: A reciprocal translocation swaps genetic material between chromosomes 9 and 22, creating a derivative chromosome 22 ($\text{der}(22)$, the Philadelphia chromosome) and a derivative chromosome 9 ($\text{der}(9)$).
- One red ABL1 probe and one green BCR probe fuse on $\text{der}(22)$, creating a merged Yellow/Fusion signal.
- The reciprocal fusion on $\text{der}(9)$ creates a second Yellow/Fusion signal.
- The un-rearranged normal chromosome 9 yields 1 Red signal, and the normal chromosome 22 yields 1 Green signal.
- Total diagnostic pattern = 2 Fusions (Yellow) + 1 Red + 1 Green (2F, 1R, 1G).
- Clinical Advantage: Because two independent fusion signals must co-occur in the same nucleus, the false-positive background rate due to random optical overlapping is exceptionally low ($<1%$).
BCR-ABL1 DUAL-COLOR DUAL-FUSION INTERPRETATION
Normal Diploid Nucleus (2R, 2G) t(9;22) Translocation Positive (2F, 1R, 1G)
+-----------------------------+ +-----------------------------------------+
| ( R ) ( G ) | | ( R ) ( G ) |
| chr 9 chr 22 | | Normal chr 9 Normal chr 22 |
| (ABL1) (BCR) | | (ABL1) (BCR) |
| | | |
| ( R ) ( G ) | | [ FUSION 1 ] [ FUSION 2 ] |
| chr 9 chr 22 | | ( YEL ) ( YEL ) |
| (ABL1) (BCR) | | der(22) der(9) |
+-----------------------------+ +-----------------------------------------+
2. Dual-Color Break-Apart Probes (e.g., ALK Rearrangements at 2p23)
Certain oncogenes partner with dozens of different chromosomal translocation mates (e.g., ALK can fuse with EML4, NPM1, KIF5B, or TFG). Designing individual dual-fusion assays for every mate is impractical.
- Probe Design: A Red fluorophore is placed on the $5'$ side of the ALK breakpoint, and a Green fluorophore is placed on the $3'$ side.
- Normal Intact Allele: The 5' and 3' probes lie directly adjacent in genomic space ($<200\text{ kb}$ apart). The optical diffraction limits of light microscopy merge the red and green emissions, producing a single Fused (Yellow) signal. A normal diploid nucleus shows 2 Fused (Yellow) signals (2F).
- Rearranged Allele: A chromosomal break separates the 5' (Red) and 3' (Green) portions. The signal pattern becomes 1 Fused (Yellow) signal (normal allele) + 1 isolated Red signal + 1 isolated Green signal (1F, 1R, 1G). Under ASCO/CAP guidelines, signals must be separated by at least 2 probe diameters to be scored as truly broken apart.
4. Specimen Preparation, Pretreatment & Hybridization Protocols
FFPE tissue sections ($3–5\text{ }\mu\text{m}$) present significant technical hurdles due to formaldehyde-induced protein-DNA crosslinking, paraffin autofluorescence, and cellular debris.
+---------------------------------------------------------------------------------------------------------+
| FFPE SLIDE PRETREATMENT PROTOCOL |
+---------------------+-----------------------------------+-----------------------------------------------+
| Step | Chemical / Physical Process | Technical Rationale & Failure Mode |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Deparaffinization**| Serial washes in Xylene followed | Removes hydrophobic paraffin wax. |
| | by 100%, 85%, and 70% ethanol | *Incomplete removal:* Probes cannot penetrate;|
| | | causes patchy, absent fluorescence. |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Heat Pretreatment**| Boiling slide in Citrate Buffer | Reverses formaldehyde crosslinks and |
| (HIER) | or EDTA buffer at 95°C–100°C for | permeabilizes hardened tissue architecture. |
| | 15 to 30 minutes | |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Proteolytic** | Incubation with **Pepsin** | Digest cytoplasmic and nuclear histone |
| **Digestion** | (in 0.01 M HCl at 37°C) or | proteins surrounding target DNA. |
| | Proteinase K for 10–25 minutes | *Underdigestion:* No probe access / faint; |
| | | *Overdigestion:* Nuclear ghosting / destroyed.|
+---------------------+-----------------------------------+-----------------------------------------------+
| **Codenaturation** | Probe mix + slide heated together | Simultaneously melts double-stranded genomic |
| | to **75°C–80°C for 5–10 minutes** | target DNA and probe DNA into single strands. |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Hybridization** | Humidified chamber at **37°C–42°C**| Allows sequence-specific probe-target annealing|
| | for 14 to 18 hours (overnight) | in formamide / dextran sulfate buffer. |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Stringency Wash** | **0.4X SSC / 0.3% NP-40 at 72°C** | Removes non-specifically bound probe; tight |
| | for exactly 2 minutes | temperature control (±1°C) is mandatory! |
+---------------------+-----------------------------------+-----------------------------------------------+
| **Counterstain** | **DAPI** in antifade mounting | Fluoresces bright blue (461 nm) to visualize |
| | medium (VECTASHIELD / p-phenyl) | nuclear boundaries under UV excitation. |
+---------------------+-----------------------------------+-----------------------------------------------+
The Critical Role of Human Cot-1 DNA
The human genome contains vast quantities of repetitive interspersed elements (e.g., Alu elements, LINE-1, and SINEs) distributed across all chromosomes. Because large BAC/PAC-derived FISH probes ($150–300\text{ kb}$) inevitably contain thousands of these repetitive sequences, the labeled probe would hybridize non-specifically throughout the entire nucleus, creating a blinding, diffuse fluorescent haze.
- Mechanism of Cot-1 Blocking: Human Cot-1 DNA (fractionated placental DNA enriched for rapidly reassociating repetitive sequences) is added in large molar excess to the probe hybridization cocktail.
- During the pre-hybridization and annealing phases, the repetitive elements in the Cot-1 DNA rapidly find and bind to the complementary repetitive sequences within the probe molecules. This selectively neutralizes the repetitive probe sequences, allowing only the unique, single-copy target gene sequences to hybridize to the patient's chromosomal target.
5. Clinical Scoring Guidelines & Quality Assurance
ASCO/CAP Guidelines for HER2/neu (ERBB2) Amplification in Breast Carcinoma
HER2 gene amplification (17q12) predicts therapeutic response to monoclonal antibodies (trastuzumab, pertuzumab) and antibody-drug conjugates (T-DXd). Testing utilizes a dual-probe cocktail containing an LSI HER2 probe (SpectrumOrange) and a CEP 17 centromere probe (SpectrumGreen).
HER2 FISH SCORING CRITERIA (ASCO/CAP)
At least 20 non-overlapping, invasive tumor nuclei scored across 2 distinct areas
Dual-Probe Ratio = (Total HER2 Signals in 20 Nuclei) / (Total CEP17 Signals in 20 Nuclei)
Average HER2 Copy Number = (Total HER2 Signals) / 20
+---------------------------------------------------------------------------------------+
| Diagnostic Category | Dual-Probe Ratio (HER2/CEP17) | Average HER2 Copy Number/Nucleus|
+----------------------+-------------------------------+---------------------------------+
| **HER2 Amplified** | **Ratio >= 2.0** | AND Average HER2 >= 4.0 signals |
| (Positive / Group 1) | | |
| **HER2 Amplified** | Ratio < 2.0 | BUT **Average HER2 >= 6.0** |
| (Positive / Group 2) | | (High polysomy / true gene amp) |
| **Equivocal** | Ratio < 2.0 | AND Average HER2 >= 4.0 & < 6.0 |
| (Group 4) | | (Requires reflex re-count/IHC) |
| **HER2 Negative** | **Ratio < 2.0** | AND **Average HER2 < 4.0** |
| (Negative / Group 5) | | |
+---------------------------------------------------------------------------------------+
Establishing Laboratory Analytical Cutoffs
Under CLSI MM07 and CAP accreditation standards, every molecular cytogenetics laboratory must establish empirical analytical cutoffs (false-positive thresholds) for each FISH assay by scoring a minimum of 20 normal control specimens (at least 200 nuclei per specimen). The clinical cutoff is statistically defined as the mean false-positive rate plus 3 standard deviations ($+3\text{ SD}$, $99.7%$ confidence level) or via beta-distribution modeling (typically $2%–5%$ for dual-fusion and $5%–10%$ for break-apart probes).
6. Chromogenic (CISH) & Silver (SISH) In Situ Hybridization
To circumvent the inherent limitations of fluorescence microscopy, brightfield in situ hybridization technologies utilize enzymatic chromogens.
+---------------------------------------------------------------------------------------------------------+
| FISH VS. CISH VS. SISH COMPARISON |
+---------------------+-----------------------+-----------------------+-----------------------------------+
| Feature | FISH | CISH | SISH |
+---------------------+-----------------------+-----------------------+-----------------------------------+
| **Microscopy** | Epifluorescence / | Standard Brightfield | Standard Brightfield Light |
| | Confocal Laser | Light Microscope | Microscope |
+---------------------+-----------------------+-----------------------+-----------------------------------+
| **Signal Carrier** | Fluorophores (FITC, | Digoxigenin/Biotin + | DNP / Biotin hapten + |
| | Texas Red, Cy3, Cy5) | AP/HRP + Fast Red/DAB | Horseradish Peroxidase (HRP) |
+---------------------+-----------------------+-----------------------+-----------------------------------+
| **Signal Form** | Fluorescent glowing | Distinct Red or Brown | Crisp, black particulate metallic |
| | dots under darkfield | chromogenic spots | silver deposits (silver nitrate) |
+---------------------+-----------------------+-----------------------+-----------------------------------+
| **Archival Life** | **Temporary**; fades | **Permanent**; slides | **Permanent**; non-fading |
| | via photobleaching | stable for decades | metallic archive |
+---------------------+-----------------------+-----------------------+-----------------------------------+
| **Morphological** | Poor; requires DAPI | **Excellent**; view | **Outstanding**; direct view of |
| **Correlation** | nuclear overlay | invasive tumor cells | nuclear grade, mitosis, and stroma|
+---------------------+-----------------------+-----------------------+-----------------------------------+
| **Multiplexing** | High (3 to 6 colors) | Moderate (Dual CISH) | Dual-color (Silver + Red AP) |
+---------------------+-----------------------+-----------------------+-----------------------------------+
7. FISH / CISH Artifacts & Systematic Troubleshooting
| Visual Anomaly | Root Cause | Corrective Action |
|---|---|---|
| Weak or Absent Fluorescent Signals | Inadequate proteolytic permeabilization; failure during codenaturation; degraded probe; fluorophore photobleaching | Increase pepsin digestion time; verify codenaturation temperature reached 75°C–80°C on calibrated hotplate; store probes in light-tight -20°C freezer; use antifade mounting medium. |
| Severe Autofluorescence Across Tissue | Unquenched collagen, red blood cells, or lipofuscin in FFPE tissue; excessive formalin fixation | Pre-treat slides with sodium borohydride ($0.1%$) or photobleach with intense white light prior to hybridization; use red/far-red fluorophores (Cy5) rather than green (FITC). |
| High Diffuse Background Haze in Nuclei | Omission or insufficient concentration of Human Cot-1 DNA; insufficient post-wash stringency | Add required concentration of Cot-1 DNA to probe mix; ensure post-hybridization wash is performed at 72°C in 0.4X SSC / 0.3% NP-40. |
| Overdigested / Ghost Nuclei (Loss of Morphology) | Excessive pepsin or Proteinase K digestion; excessive heat-induced epitope retrieval | Reduce proteolytic digestion time or lower enzyme concentration; reduce boiling time in citrate buffer. |
| Low Hybridization Specificity / Cross-Hybridization | Stringency wash temperature too low ($<71^\circ\text{C}$); wash buffer salt concentration too high | Calibrate water bath thermometer to ensure 72°C ± 1°C; verify 0.4X SSC concentration. |
| Patchy Probe Hybridization Across Slide | Incomplete paraffin removal (residual wax); air bubbles trapped under coverslip during hybridization | Extend xylene deparaffinization steps; apply rubber cement seal evenly around coverslip edges without trapping air bubbles. |
Loading diagram...
Test Your Knowledge
A molecular pathology laboratory is evaluating a non-small cell lung carcinoma (NSCLC) biopsy for ALK gene rearrangements using a dual-color break-apart probe (5' ALK labeled in Red, 3' ALK labeled in Green). When examining the tumor interphase nuclei under an epifluorescence microscope, which signal pattern confirms the presence of a pathogenic ALK rearrangement?
A
B
C
D
Test Your Knowledge
During the optimization of an interphase FISH assay using a 200-kb BAC-derived locus-specific probe, the technologist observes heavy, non-specific fluorescent background staining distributed uniformly across the entire nucleoplasm. What critical reagent was most likely omitted from the hybridization cocktail?
A
B
C
D
Test Your Knowledge
A technologist performs proteolytic pretreatment on an FFPE tissue section using excessive concentrations of pepsin for an extended incubation time. Upon microscopic examination following FISH hybridization, what histological artifact will be observed?
A
B
C
D